Background: Clinical studies have demonstrated better outcomes in percutaneous coronary intervention (PCI) guided by coronary fractional flow reserve (FFR) when compared with angiography. We examined the long term clinical outcomes of medical treatment versus revascularization in patients with intermediate stenoses guided by pressure wire. Methods: All patients who underwent FFR measurement for intermediate coronary lesions (50% to 75% visionally) in our center from June 2002 to December 2009 were analyzed. Revascularization treatment is performed in patients with FFR of Ͻ0.75, while the rest were treated with optimal medical therapy. All patients were prospectively followed up for major adverse cardiac events (MACE) of death, myocardial infarction, target vessel revascularization (TVR) and stent thrombosis. Results: A total of 646 pts with 812 lesions were enrolled in the study cohort. Among them, the mean age was 58.2Ϯ10.5 years and males constitute 78.5%. Based on FFR measurement, 368 (57.0%) patients were treated medically while the rest underwent revascularization, among which 91.7% received PCI. At a mean follow-up duration of 29.7Ϯ16.0 months, 7(1.9%) patients in medical therapy group died while 9(3.2%) patients in revascularizated group. Fifty-three (14.4%) patients underwent MACE events in medical therapy group while 32 (11.5%) patients in revascularized group. There was no statistical difference in all the clinical endpoints between the two groups. Conclusions: FFR-guided medical treatment of intermediate lesions is safe and is associated with low incidence of TVR and MACE at long term follow-up. This has significant cost-saving impact in real world practice.
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The role of collateral pressure index assessing collateral function and coronary hemodynamics in patients with total or nearly total occluded coronary lesions Conclusions: Endothelium-dependent vasomotion is heterogenous within the conduit system. Despite similar degrees of plaque burden, the LMCA and its most adjacent epicardial segment display greater degrees of vascular stiffness than the remainder of the more distal epicardial tree. These observations may provide mechanistic insights into the focal nature of coronary plaque progression and stability in vivo.
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Outcomes of Deferred FFR-Negative Stenoses: Real World Experience in a Community-Based Cardiac Referral Center
Michael Ho 1 , Michael Ho 1 , Shuwen Chen 1 1 Kaiser Permanente Medical Center, Santa Clara, CA Background: Fractional flow reserve (FFR) guided percutaneous coronary intervention (PCI) has been validated in the FAME trial, which demonstrated a statistically significant reduction in the composite of death or myocardial infarction compared to an angiographic-guided approach. At two years of follow-up, 3.2% of patients who had deferral of a FFR negative stenosis (Ͼ 0.80) returned for revascularization of the deferred lesion. Only 0.2% of the deferred lesions resulted in a late myocardial infarction (MI). We sought to evaluate the outcomes of FFR-deferred lesions in a community-based cardiac referral center. Methods: A retrospective analysis was conducted of the FFR cases performed at Kaiser Permanente Medical Center in Santa Clara, CA over a two-year period. Outcomes of the patients who had deferral of FFR negative lesions were assessed out to two years. Results: 5,558 patients underwent diagnostic coronary catheterization from 2010-2011. FFR was performed on 219 patients with a total of 224 intermediate coronary lesions undergoing hemodynamic FFR assessment. 144 stenoses (64.3% of total FFRs) were found to be Ͼ0.80 and PCI was deferred in these 140 patients. From this cohort, 38 lesions from a total of 32 patients returned for subsequent coronary angiography. Reasons for repeat angiography included post-cardiac transplant surveillance, stable angina, unstable angina, or MI. Of the 32 patients, 10 patients (7.1% of total deferred FFR patients) underwent revascularization of the originally deferred lesion, with 8 undergoing PCI and 2 undergoing CABG surgery. Average length from deferral to subsequent revascularization was 257 days. None of the originally deferred lesions resulted in a late MI or in-hospital death out to two years of follow-up. Conclusions: Fractional flow reserve assessment has been increasingly adopted at our cardiac referral center and accounted for 3.9% of patients that underwent coronary angiography over the initial two years of adoption. FFR-guided therapy yielded outcomes that were comparable to that seen in the FAME study, with 7.1% of deferred lesions requiring revascularization and no deferred stenosis resulting in a subsequent MI or in-hospital death. Background: Fractional flow reserve (FFR) is helpful to evaluate physiological severity of coronary stenosis. Pharmacologic stimulus such as adenosine triphosphate (ATP) is needed to obtain maximal hyperemia. Nicorandil, which is an ATP sensitive potassium channel opener, recognized as vasodilator of epicardial and resistance vessels. However, safety and feasibility of FFR with nicorandil has not been fully evaluated yet. Methods: This study consisted of 32 patients with 39 de novo lesions which underwent FFR measurements with both ATP and nicorandil stimulus. All patients first received intravenous ATP infusion at a rate of 150 g/kg/min and measured FFR-ATP. After the recovery to baseline was verified, patients received intracoronary nicorandil (1.5 mg to left coronary artery or 1.0mg to right coronary artery) to obtain maximal hyperemia and measured FFR-Nico. Results: A total of 18 left anterior descending, 10 left circumflex, and 11 right coronary arteries were evaluated. Mean diameter stenosis by QCA was 58.8Ϯ14.8%. A strong correlation was observed between FFR-ATP and FFR-Nico (rϭ0.960, pϽ0.0001). The agreement between the 2 sets of measurements was also high, with a mean difference of 0.0003 and 2SD of 0.0696. The mean aortic pressure drop during pharmacological stimulus was significantly larger in ATP than in niocrandil (10.6Ϯ9.5 mmHg vs. 5.4Ϯ7.2 mmHg, pϭ0.01). 
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Coronary Endothelial Dysfunction Predicts Long-term Prognosis In Patients With Successful First Generation Drug-eluting Stents Implantation Without Residual Stenosis At Chronic Stage
